Literature DB >> 15342681

Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products.

Jennifer S Dickinson Zimmer1, Douglas F Dyckes, David A Bernlohr, Robert C Murphy.   

Abstract

Leukotriene A(4) (LTA(4)) is a chemically reactive conjugated triene epoxide product derived from 5-lipoxygenase oxygenation of arachidonic acid. At physiological pH, this reactive compound has a half-life of less than 3 s at 37 degrees C and approximately 40 s at 4 degrees C. Regardless of this aqueous instability, LTA(4) is an intermediate in the formation of biologically active leukotrienes, which can be formed through either intracellular or transcellular biosynthesis. Previously, epithelial fatty acid binding protein (E-FABP) present in RBL-1 cells was shown to increase the half-life of LTA(4) to approximately 20 min at 4 degrees C. Five FABPs (adipocyte FABP, intestinal FABP, E-FABP, heart/muscle FABP, and liver FABP) have now been examined and also found to increase the half-life of LTA(4) at 4 degrees C to approximately 20 min with protein present. Stabilization of LTA(4) was examined when arachidonic acid was present to compete with LTA(4) for the binding site on E-FABP. Arachidonate has an apparent higher affinity for E-FABP than LTA(4) and was able to completely block stabilization of the latter. When E-FABP is not saturated with arachidonate, FABP can still stabilize LTA(4). Several lipoxygenase products, including 5-hydroxyeicosatetraenoic acid, 5,6-dihydroxyeicosatetraenoic acid, and leukotriene B(4), were found to have no effect on the stability of LTA(4) induced by E-FABP even when present at concentrations 3-fold higher than LTA(4).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342681     DOI: 10.1194/jlr.M400240-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  20 in total

Review 1.  The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

Authors:  Zora Djuric
Journal:  Nutr Rev       Date:  2011-12       Impact factor: 7.110

Review 2.  Location, location, location: compartmentalization of early events in leukotriene biosynthesis.

Authors:  Marcia E Newcomer; Nathaniel C Gilbert
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

3.  Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds.

Authors:  Joshua R Mauney; Trang Nguyen; Kelly Gillen; Carl Kirker-Head; Jeffrey M Gimble; David L Kaplan
Journal:  Biomaterials       Date:  2007-08-31       Impact factor: 12.479

Review 4.  The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis.

Authors:  Liza Makowski; Gökhan S Hotamisligil
Journal:  Curr Opin Lipidol       Date:  2005-10       Impact factor: 4.776

5.  Fatty acid binding protein 4/aP2-dependent BLT1R expression and signaling.

Authors:  Ann V Hertzel; Hongliang Xu; Michael Downey; Nicholas Kvalheim; David A Bernlohr
Journal:  J Lipid Res       Date:  2017-05-25       Impact factor: 5.922

Review 6.  Lysophospholipid acyltransferases and leukotriene biosynthesis: intersection of the Lands cycle and the arachidonate PI cycle.

Authors:  Robert C Murphy; Giancarlo Folco
Journal:  J Lipid Res       Date:  2019-01-03       Impact factor: 5.922

Review 7.  Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity.

Authors:  Atsushi Kato; Robert P Schleimer
Journal:  Curr Opin Immunol       Date:  2007-10-24       Impact factor: 7.486

8.  Determination of leukotriene A(4) stabilization by S100A8/A9 proteins using mass spectrometry.

Authors:  Christopher L Rector; Robert C Murphy
Journal:  J Lipid Res       Date:  2009-03-05       Impact factor: 5.922

Review 9.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

Review 10.  Metabolic functions of FABPs--mechanisms and therapeutic implications.

Authors:  Gökhan S Hotamisligil; David A Bernlohr
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.